Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
4.360
+0.200 (4.81%)
At close: Sep 19, 2024, 4:00 PM
4.395
+0.034 (0.79%)
After-hours: Sep 19, 2024, 7:32 PM EDT
Zentalis Pharmaceuticals Market Cap
Zentalis Pharmaceuticals has a market cap or net worth of $310.03 million as of September 19, 2024. Its market cap has decreased by -82.73% in one year.
Market Cap
310.03M
Enterprise Value
-72.33M
1-Year Change
-82.73%
Ranking
Category
Stock Price
$4.36
Market Cap Chart
Since April 3, 2020, Zentalis Pharmaceuticals's market cap has decreased from $762.70M to $310.03M, a decrease of -59.35%. That is a compound annual growth rate of -18.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2024 | 295.80M | -72.41% |
| Dec 29, 2023 | 1.07B | -6.73% |
| Dec 30, 2022 | 1.15B | -69.82% |
| Dec 31, 2021 | 3.81B | 80.54% |
| Dec 31, 2020 | 2.11B | 176.58% |
| Apr 3, 2020 | 762.70M | - |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kamada | 306.04M |
| PepGen | 301.78M |
| ProKidney | 301.26M |
| ADC Therapeutics | 299.61M |
| Precigen | 299.58M |
| Heron Therapeutics | 295.75M |
| TScan Therapeutics | 293.48M |
| SOPHiA GENETICS | 289.33M |